UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000002407
Receipt number R000002944
Scientific Title Phase II study of Bevacizumab in combination with FOLFIRI as second-line therapy for patients with metastatic colorectal cancer who have progressed on Bevacizumab with Oxaliplatin-based chemotherapy
Date of disclosure of the study information 2009/09/01
Last modified on 2013/06/27 15:21:55

No. Disposal Last modified on Item of update
1 Insert 2009/08/31 13:47:38
2 Update 2013/06/27 15:21:55 Recruitment status